| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |